Navigation Links
Following colorectal cancer surgery, longer delay before chemotherapy associated with worse survival
Date:6/4/2011

An analysis of data from previously published studies indicates that longer time to beginning adjuvant chemotherapy after surgery for colorectal cancer is associated with worse survival, according to a study in the June 8 issue of JAMA, a theme issue on cancer. The study is being published early online to coincide with its presentation at the American Society of Clinical Oncology 2011 Annual Meeting.

"Colorectal cancer (CRC) is the third leading cause of cancer mortality in the Western world. While surgical resection [removal] remains the cornerstone of management for patients with stage I-III disease, a considerable proportion of patients will ultimately relapse and die from their disease," according to background information in the article. "Adjuvant chemotherapy [AC; chemotherapy after surgery] improves survival among patients with resected colorectal cancer. However, the optimal timing from surgery to initiation of AC is unknown." There is also a question of the benefit of beginning chemotherapy after a certain time period, typically believed to be 12 weeks.

James J. Biagi, M.D., of Queen's University, Kingston, Ontario, Canada, and colleagues conducted a review and meta-analysis of studies that assessed the relationship between time to AC and survival in CRC. Studies were only included if relevant prognostic factors were adequately described and either comparative groups were balanced or results adjusted for these prognostic factors. The researchers identified 10 eligible studies involving 15,410 patients (7 published articles, 3 abstracts) that met study criteria for inclusion. Nine of the studies were cohort or population based and 1 was a secondary analysis from a randomized trial of chemotherapy.

The researchers found that meta-analysis indicated that a 4-week increase in time to AC was associated with a significant decrease (14 percent) in both overall survival and disease-free survival. There was no significant heterogeneity (lack of uniformity) among included studies. Results remained significant after adjustment for potential publication bias and when the analysis was repeated to exclude studies of largest weight.

"The effect of AC on survival is thought to be eradication of micro-metastatic deposits in a proportion of patients who would otherwise be destined to have cancer recurrence. There is a substantial theoretical rationale to initiate AC promptly after curative surgery," the authors write.

Regarding the question of after what time period would beginning chemotherapy appear to be of limited benefit, the authors found that their results indicate survival of 48 percent if chemotherapy is administered at 12 weeks instead of 4 weeks, suggesting there may be some benefit to chemotherapy beyond a 12-week window, and that a reasonable limit may be more in the order of 4 to 5 months.

These findings suggest that timing of AC plays a critical role in the management and outcomes of patients with CRC and that it would be prudent for clinicians and jurisdictions to avoid delays in access to chemotherapy, the researchers write. "Our results indicate that at a population level, the effect of delays might be substantial. With approximately 140,000 new cases of CRC diagnosed in the United States in 2009, of which roughly 35 percent or 49,000 had stage III disease, the population at risk is sizeable."

"In conclusion, our results demonstrate a significant adverse association between time to AC and survival in CRC, supporting a position that clinicians and jurisdictions need to optimize patient flow logistics to minimize time to AC," the authors write. "Our results provide further validation of the intuitive concept of early time to AC. Physicians may need to more carefully consider timing when discussing AC with patients."


'/>"/>

Contact: Christina Archibald
christina.archibald@queensu.ca
613-533-2877
JAMA and Archives Journals
Source:Eurekalert

Related medicine news :

1. PolicyLink CEO Angela Glover Blackwell Released the Following Statement on First Lady Michelle Obamas Childhood Obesity Initiative
2. Connecticut Board Considers Warning About Risk Of Stroke Following Chiropractic Neck Manipulation
3. Study supports alternative anti-seizure medication following acute brain injury
4. International Medical Corps on the Ground in Chile, Following 8.8-Magnitude Earthquake
5. Long Term Care Insurance Leader Seeks 320 New Agents in 2010, Following Strong 2009 Growth
6. Poor More Likely to Die Following Heart Surgery
7. New Study Identifies Cause of Severe Disequilibrium and Significant Memory Loss Following Stapedectomy Surgery
8. ShelterBox Aid en route to Mexico Following Earthquake
9. Patient-physician compatibility increases odds of following doctors orders
10. Lottery game helps to assess brain damage following stroke
11. Falls and follow-ups: Medical attention following a fall critical to senior health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... 21, 2017 , ... Hanna Boys Center http://www.hannacenter.org ... the keynote speaker at its second Professional Networking Breakfast on March 9, 2017. ... comprehensive strategies to create and expand opportunities for boys and young men of ...
(Date:2/21/2017)... ... February 21, 2017 , ... As recently as 2015, rhinoplasty was one of ... of Plastic Surgeons. Some patients want to make a change in the appearance of ... their breathing ability. The team at usrhinoplasty.org is expanding its article database ...
(Date:2/21/2017)... (PRWEB) , ... February 21, 2017 , ... Ray Insurance ... communities in and around Tarrant County, is embarking on a six month charity event ... and treatments for cancer. , Cancer is one of the deadliest diseases in America; ...
(Date:2/21/2017)... ... February 21, 2017 , ... American Veterinarian™, the premier multimedia ... launching its first bi-monthly issue of 2017 in February. The inaugural issue will ... One Health. , In making the announcement, American Veterinarian™ Publisher Chris Hennessy ...
(Date:2/21/2017)... ... 2017 , ... Each February the nation reflects upon African ... American History Month ). This month-long celebration encourages reflection upon the ... people, but also the opportunity to examine the trends of addiction among African ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... 21, 2017 Cadence Design Systems, Inc. (NASDAQ: ... Tensilica ® Fusion F1 DSP is part of the ... The licensable IP targets SoCs designed for battery-powered sensor nodes ... leveraged the Fusion F1 DSP both to implement the IEEE ... trigger, audio identification and sensor fusion on a single DSP. ...
(Date:2/21/2017)... and Markets has announced the addition of the "Rosacea Drugs Price ... ... Analysis and Strategies - 2016, provides drug pricing data and benchmarks in ... What are the key drugs marketed for Rosacea ... market? What are the unit prices and annual treatment ...
(Date:2/20/2017)... , Feb. 21, 2017 Taiwan Biophotonic ... provider of non-invasive vital signs sensing solutions, today announced ... first finger-free wrist pulse oximeter, the oCare TM Pro ... wearable healthcare and medical devices space.  tBPC,s ... provides a non-invasive, simple and reliable method to measure ...
Breaking Medicine Technology: